BIOREM Inc.
BRM.V
TSX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -59.66% | 48.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -59.66% | 48.74% | |||
| Cost of Revenue | -50.56% | 34.38% | |||
| Gross Profit | -76.51% | 85.41% | |||
| SG&A Expenses | -43.48% | 37.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -49.22% | 33.94% | |||
| Operating Income | -95.19% | 138.30% | |||
| Income Before Tax | -92.61% | 131.48% | |||
| Income Tax Expenses | -91.27% | 92.38% | |||
| Earnings from Continuing Operations | -92.98% | 145.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -92.98% | 145.57% | |||
| EBIT | -95.19% | 138.30% | |||
| EBITDA | -92.97% | 124.81% | |||
| EPS Basic | -93.52% | 164.38% | |||
| Normalized Basic EPS | -93.17% | 149.33% | |||
| EPS Diluted | -93.66% | 176.89% | |||
| Normalized Diluted EPS | -93.23% | 157.55% | |||
| Average Basic Shares Outstanding | 8.49% | -7.08% | |||
| Average Diluted Shares Outstanding | 9.40% | -10.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||